Also trades as: RAFLF (OTC) · $vol 0M
BSL.SI SES
Raffles Medical Group Ltd
1W: -1.2%
1M: -4.7%
3M: -10.9%
YTD: -19.6%
1Y: -19.6%
3Y: -31.1%
5Y: -35.4%
S$0.82 ($0.64)
+0.00 (+0.61%)
Weekly Expected Move ±1.6%
S$1
S$1
S$1
S$1
S$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$106M
+22.9% ▲
5Y CAGR: -4.5%
Capital Expenditures
$8M
+62.4% ▲
5Y CAGR: -34.1%
Free Cash Flow
$98M
+50.2% ▲
5Y CAGR: +7.1%
Dividends Paid
$46M
-3.8% ▼
Buybacks
$20M
+0.0% ▲
Net Change in Cash
-$33M
-3014.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $84M | $144M | $90M | $62M | $71M |
| Depreciation & Amort. | $39M | $40M | $38M | $43M | $43M |
| Stock-Based Comp. | $2M | $3M | $3M | $3M | $0 |
| Change in Working Capital | $14M | -$33M | $96M | -$21M | -$12M |
| Other Non-Cash Items | $6M | $4M | -$38M | -$1M | $4M |
| Operating Cash Flow | $160M | $196M | $189M | $86M | $106M |
| — Investing Activities — | |||||
| Capital Expenditures | -$53M | -$25M | -$21M | -$19M | -$10M |
| Acquisitions (Net) | $45K | $161K | $0 | $0 | -$46M |
| Investment Purchases | -$65K | $0 | $0 | $0 | $0 |
| Investment Sales | $3M | $0 | $0 | $0 | $0 |
| Other Investing | -$2M | $2M | $8M | $9M | $0 |
| Investing Cash Flow | -$52M | -$23M | -$12M | -$10M | -$56M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$5M | -$107M | -$11M | -$14M | -$4M |
| Stock Repurchased | -$3M | -$24M | -$6M | $0 | -$20M |
| Dividends Paid | -$37M | -$52M | -$71M | -$45M | -$46M |
| Other Financing | -$2M | -$763K | $2M | -$18M | -$13M |
| Financing Cash Flow | -$47M | -$184M | -$86M | -$76M | -$82M |
| Net Change in Cash | $62M | -$12M | $90M | $1M | -$33M |
| Cash End of Period | $264M | $252M | $343M | $344M | $311M |
| Free Cash Flow | $107M | $171M | $169M | $65M | $98M |